CRO Activity and Intelligence Report 2Q16

15 July 2016

BioPharm Insight’s quarterly CRO report includes analytics based on BPI data regarding key aspects of the contract services sector, including most used CROs, most active sponsors and therapeutic area breakdown of clinical trials.

Also included is select editorial coverage from 2Q16 such as analyses on what the CRO sector may face as a result of Brexit, digital monitoring devices, contract scrutiny to protect against the risk of cybersecurity attacks, the 2018 EU clinical trials directive, changes to EU’s medical device/diagnostic regulations and South Korea’s s increase in foreign-sponsored trials. Lastly, the report also includes articles based on interviewing drug development executives about their CRO needs and strategies.

Complete the form on the right to gain access to all of this intel and more!